The verification of known SLE genes (IFIH1, CD44, and TNIP1/ANXA6) in datasets that did not previously identify them is categorical evidence of the validity of OASIS as a novel gene-hunting tool. This evidence concerns the gene IFIH1 and systemic lupus erythematosus.